Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340

10/13/2026
Impact: 80
Healthcare

Morgan Stanley analyst Ricky Goldwasser has maintained an Overweight rating on Charles River (NYSE: CRL) and raised the price target from $300 to $340. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: